Diabetes Types: LADA and MODY

Latent autoimmune diabetes of adulthood (LADA) is typically diagnosed after age 25.

MODY is a single inherited condition affecting insulin secretion.

In pancreatic diabetes, the endocrine pancreas fails before the exocrine pancreas.

For gestational diabetes, insulin is the only recommended treatment.

Approximately 20% of those diagnosed with type 2 diabetes may actually have LADA.

Genetic testing can confirm a diagnosis of Maturity Onset Diabetes of the Young (MODY).

Latent Autoimmune Diabetes of Adulthood (LADA)

Diagnosed after age 25, similar to type 1 diabetes
Accounts for approximately 20% of type 2 diabetes diagnoses
Slower onset compared to type 1 diabetes
Characterized by positive antibodies and low or no C-peptide levels
Typically, no family history of diabetes

Maturity Onset Diabetes of the Young (MODY)

A collection of at least 6 inherited diseases affecting insulin secretion
Exhibits dominant inheritance characteristics
Normal insulin sensitivity, but impaired insulin secretion
Diagnosis confirmed through genetic testing

Pancreatic Diabetes

Results from pancreatic failure, potentially secondary to ETOH abuse, trauma, or repeat pancreatitis
Exocrine pancreas generally fails before the endocrine pancreas
Treatment requires pancreatic enzyme replacement and insulin

Gestational Diabetes

Glucose intolerance first diagnosed during pregnancy
Some definitions require a return to normal glucose levels after pregnancy
Closely related to type 2 diabetes
Treatment typically involves insulin, with some support for the use of sulfonylureas and metformin

Learn about Latent Autoimmune Diabetes of Adulthood (LADA) and Maturity Onset Diabetes of the Young (MODY), including their characteristics, diagnosis, and differences from other types of diabetes.